{"pmid":32359180,"title":"Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.","text":["Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.","Cutaneous manifestation has been reported in 0.2% of patients infected by COVID-19 in China, and 18 out of 88 patients from Italy. The most commonly reported features are exanthomatous rash, urticaria, chickenpox like vesicles, petechiae, and acute hemorrhagic edema of infancy. Herein, we report one case of pityriasis rosea in a patient infected with COVID-19.","J Eur Acad Dermatol Venereol","Ehsani, Amir Hooshang","Nasimi, Maryam","Bigdelo, Zeinab","32359180"],"abstract":["Cutaneous manifestation has been reported in 0.2% of patients infected by COVID-19 in China, and 18 out of 88 patients from Italy. The most commonly reported features are exanthomatous rash, urticaria, chickenpox like vesicles, petechiae, and acute hemorrhagic edema of infancy. Herein, we report one case of pityriasis rosea in a patient infected with COVID-19."],"journal":"J Eur Acad Dermatol Venereol","authors":["Ehsani, Amir Hooshang","Nasimi, Maryam","Bigdelo, Zeinab"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32359180","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/jdv.16579","keywords":["covid-19","pityriasis rosea","coronavirus","cutaneous"],"locations":["China","Italy"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138495317442561,"score":9.490897,"similar":[{"pmid":32475003,"title":"The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.","text":["The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.","A new type of coronavirus family (SARS-CoV-2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID-19). In the literature, cutaneous symptoms related to the disease are generally emphasized. However, it is not yet known whether this new SARS-CoV-2 virus, which has entered our lives, plays a role in the etiopathogenesis of dermatological diseases. The patients who were admitted to the dermatology outpatient clinic between 1 April and May 15, 2019, and on 1 April and May 15, 2020 were retrospectively analyzed by searching the hospital automation system and patient files. The reason for the same months to be included in the study was to exclude seasonal effects on the diseases. After pandemic, the number of patients with Pityriasis rosea and Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic. Our study is the first study showing pityriasis rosea increase during the pandemic period. We think that this increase is related to HHV-6 reactivation. Herein, we wanted to draw attention to two diseases in which Human Herpes 6 (HHV-6) was accused in etiopathogenesis: Kawasaki disease and Pityriasis rosea. This article is protected by copyright. All rights reserved.","Dermatol Ther","Dursun, Recep","Temiz, Selami Aykut","32475003"],"abstract":["A new type of coronavirus family (SARS-CoV-2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID-19). In the literature, cutaneous symptoms related to the disease are generally emphasized. However, it is not yet known whether this new SARS-CoV-2 virus, which has entered our lives, plays a role in the etiopathogenesis of dermatological diseases. The patients who were admitted to the dermatology outpatient clinic between 1 April and May 15, 2019, and on 1 April and May 15, 2020 were retrospectively analyzed by searching the hospital automation system and patient files. The reason for the same months to be included in the study was to exclude seasonal effects on the diseases. After pandemic, the number of patients with Pityriasis rosea and Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic. Our study is the first study showing pityriasis rosea increase during the pandemic period. We think that this increase is related to HHV-6 reactivation. Herein, we wanted to draw attention to two diseases in which Human Herpes 6 (HHV-6) was accused in etiopathogenesis: Kawasaki disease and Pityriasis rosea. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Dursun, Recep","Temiz, Selami Aykut"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32475003","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/dth.13730","keywords":["covid-19","hhv-6","kawasaki disease","pityriasis rosea"],"locations":["Wuhan","China","Pityriasis","Kawasaki","Kawasaki","Pityriasis","Pityriasis","Kawasaki"],"countries":["China","Japan"],"countries_codes":["CHN|China","JPN|Japan"],"topics":["Prevention"],"weight":1,"_version_":1668341932654329856,"score":261.0584},{"pmid":32386446,"title":"Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.","text":["Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.","Since CoronaVirus Disease 19 (COVID-19) was declared as a pandemic, all medical specialties were at the front, including dermatology. Daily, there are observations mentioning possible cutaneous manifestations of Sars-Cov-2. Among these manifestations, the most often was a rash which could be erythematous, morbilliform or urticarial mimicking viral exanthema, or chickenpox-like vesicles [1-3]. Anecdotally, dengue-like petechial eruption was reported [4].","J Eur Acad Dermatol Venereol","Janah, Hicham","Zinebi, Ali","Elbenaye, Jalal","32386446"],"abstract":["Since CoronaVirus Disease 19 (COVID-19) was declared as a pandemic, all medical specialties were at the front, including dermatology. Daily, there are observations mentioning possible cutaneous manifestations of Sars-Cov-2. Among these manifestations, the most often was a rash which could be erythematous, morbilliform or urticarial mimicking viral exanthema, or chickenpox-like vesicles [1-3]. Anecdotally, dengue-like petechial eruption was reported [4]."],"journal":"J Eur Acad Dermatol Venereol","authors":["Janah, Hicham","Zinebi, Ali","Elbenaye, Jalal"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32386446","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jdv.16623","keywords":["covid 19","sars-cov-2","acral","cutaneous","erythema multiforme","palms","targetoid"],"topics":["Case Report"],"weight":1,"_version_":1666340101972557824,"score":194.37889},{"pmid":32455505,"title":"Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.","text":["Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.","We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening cases of children presenting with fever and eruptions with mucous membrane involvement - erythema multiforme and Kawasaki disease - associated with COVID-19.","J Eur Acad Dermatol Venereol","Labe, P","Ly, A","Sin, C","Nasser, M","Chapelon-Fromont, E","Ben Said, P","Mahe, E","32455505"],"abstract":["We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening cases of children presenting with fever and eruptions with mucous membrane involvement - erythema multiforme and Kawasaki disease - associated with COVID-19."],"journal":"J Eur Acad Dermatol Venereol","authors":["Labe, P","Ly, A","Sin, C","Nasser, M","Chapelon-Fromont, E","Ben Said, P","Mahe, E"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32455505","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jdv.16666","keywords":["covid-19","kawasaki disease","coranovirus","erythema multiforme"],"locations":["Kawasaki","Kawasaki"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Case Report"],"weight":1,"_version_":1667881798469681153,"score":193.55838},{"pmid":32381430,"pmcid":"PMC7189855","title":"Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.","text":["Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.","BACKGROUND: Various cutaneous manifestations have been observed in patients with COVID-19 infection. However, overall similarities in the clinical presentation of these dermatological manifestations have not yet been summarized. OBJECTIVE: This review aims to provide an overview of various cutaneous manifestations in patients with COVID-19 through three case reports and a literature review. METHODS: A literature search was conducted using PubMed, OVID, and Google search engines for original and review articles. Studies written in the English language that mentioned cutaneous symptoms and COVID-19 were included. RESULTS: Eighteen articles and three additional cases reported in this paper were included in this review. Of these studies, 6 are case series and 12 are case report studies. The most common cutaneous manifestation of COVID-19 was found to be maculopapular exanthem (morbilliform), presenting in 36.1% (26/72) patients. The other cutaneous manifestations included: a papulovesicular rash (34.7%, 25/72), urticaria (9.7%, 7/72), painful acral red purple papules (15.3%, 11/72) of patients, livedo reticularis lesions (2.8%, 2/72) and petechiae (1.4%, 1/72). Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet. Skin lesion development occurred before the onset of respiratory symptoms or COVID-19 diagnosis in 12.5% (9/72) of the patients, and lesions spontaneously healed in all patients within 10 days. Majority of the studies reported no correlation between COVID-19 severity and skin lesions. CONCLUSION: Infection with COVID-19 may result in dermatological manifestations with various clinical presentations, which may aid in the timely diagnosis of this infection.","J Dermatol Sci","Sachdeva, Muskaan","Gianotti, Raffaele","Shah, Monica","Lucia, Bradanini","Tosi, Diego","Veraldi, Stefano","Ziv, Michael","Leshem, Eyal","Dodiuk-Gad, Roni P","32381430"],"abstract":["BACKGROUND: Various cutaneous manifestations have been observed in patients with COVID-19 infection. However, overall similarities in the clinical presentation of these dermatological manifestations have not yet been summarized. OBJECTIVE: This review aims to provide an overview of various cutaneous manifestations in patients with COVID-19 through three case reports and a literature review. METHODS: A literature search was conducted using PubMed, OVID, and Google search engines for original and review articles. Studies written in the English language that mentioned cutaneous symptoms and COVID-19 were included. RESULTS: Eighteen articles and three additional cases reported in this paper were included in this review. Of these studies, 6 are case series and 12 are case report studies. The most common cutaneous manifestation of COVID-19 was found to be maculopapular exanthem (morbilliform), presenting in 36.1% (26/72) patients. The other cutaneous manifestations included: a papulovesicular rash (34.7%, 25/72), urticaria (9.7%, 7/72), painful acral red purple papules (15.3%, 11/72) of patients, livedo reticularis lesions (2.8%, 2/72) and petechiae (1.4%, 1/72). Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet. Skin lesion development occurred before the onset of respiratory symptoms or COVID-19 diagnosis in 12.5% (9/72) of the patients, and lesions spontaneously healed in all patients within 10 days. Majority of the studies reported no correlation between COVID-19 severity and skin lesions. CONCLUSION: Infection with COVID-19 may result in dermatological manifestations with various clinical presentations, which may aid in the timely diagnosis of this infection."],"journal":"J Dermatol Sci","authors":["Sachdeva, Muskaan","Gianotti, Raffaele","Shah, Monica","Lucia, Bradanini","Tosi, Diego","Veraldi, Stefano","Ziv, Michael","Leshem, Eyal","Dodiuk-Gad, Roni P"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381430","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jdermsci.2020.04.011","keywords":["covid-19","cutaneous manifestations","review","skin"],"topics":["Case Report"],"weight":1,"_version_":1666419683361816576,"score":170.9174},{"pmid":32500642,"title":"Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not \"varicella-like\".","text":["Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not \"varicella-like\".","Several articles recently reported a \"varicella-like\" rash in patients with COVID-19 [1,2]. We observed similar cases at our institution. However, although we agree that the clinical picture is original, we reject that \"varicella-like\" denomination since clinical presentation, as well as some histologic features that we wish to report here for the first time, make it clearly different from varicella. Three patients with a vesicular rash associated with COVID-19 (RT-PCR test on a nasopharyngeal swab specimen positive for SARS-CoV-2 ARN) were seen at our institution in April, 2020. A biopsy of a vesicle was performed in each. Multiple levels with H&E stain were done; the slides were reviewed independently by two pathologists; only concordant data were validated. A test for SARS-CoV-2 was performed on a vesicle in two patients, and a direct immunofluorescence test on perilesional skin in one.","J Eur Acad Dermatol Venereol","Mahe, A","Birckel, E","Merklen, C","Lefebvre, P","Hannedouche, C","Jost, M","Droy-Dupre, L","32500642"],"abstract":["Several articles recently reported a \"varicella-like\" rash in patients with COVID-19 [1,2]. We observed similar cases at our institution. However, although we agree that the clinical picture is original, we reject that \"varicella-like\" denomination since clinical presentation, as well as some histologic features that we wish to report here for the first time, make it clearly different from varicella. Three patients with a vesicular rash associated with COVID-19 (RT-PCR test on a nasopharyngeal swab specimen positive for SARS-CoV-2 ARN) were seen at our institution in April, 2020. A biopsy of a vesicle was performed in each. Multiple levels with H&E stain were done; the slides were reviewed independently by two pathologists; only concordant data were validated. A test for SARS-CoV-2 was performed on a vesicle in two patients, and a direct immunofluorescence test on perilesional skin in one."],"journal":"J Eur Acad Dermatol Venereol","authors":["Mahe, A","Birckel, E","Merklen, C","Lefebvre, P","Hannedouche, C","Jost, M","Droy-Dupre, L"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500642","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/jdv.16706","keywords":["covid-19","sars-cov-2","acantholysis","coronavirus","skin rash","varicella"],"e_drugs":["Helium"],"topics":["Case Report"],"weight":1,"_version_":1668890966346432512,"score":150.21043}]}